Table 1 Clinical features of patients

Clinics

 Sex ratio (F/M)

40/67

 Age (y) ± SD

64 ± 11

 Comorbidities

  Cardio-vascular

45 (42%)

  Diabetes

15(14%)

Surgery

 Surgical resection

  Sub-lobar n (%)

9 (8%)

  Lobectomy n (%)

89 (83%)

  Bilobectomy n (%)

3 (3%)

  Pneumonectomy n (%)

6 (5%)

 Complete resection (R0) n (%)

107 (100%)

 Side (D/G)

103/73

Oncology

 Histological type

  Adenocarcinomas n (%)

107 (100%)

 TNM (IASLC 2009)

  Tx n (%)

3 (2%)

  T1 n (%)

34 (32%)

  T2 n (%)

49 (46%)

  T3 n (%)

17 (16%)

  T4 n (%)

4 (4%)

  Nx

5 (5%)

  N0 n (%)

62 (58%)

  N1 n (%)

14 (13%)

  N2 n (%)

26 (24%)

  M0 n (%)

104 (97%)

  M1 n (%)

3 (3%)

 Stage

  I A n (%)

28 (26%)

  I B n (%)

24 (22%)

  II A n (%)

6 (6%)

  II B n (%)

18 (17%)

  III A n (%)

24 (22%)

  III B n (%)

3 (3%)

  IV n (%)

4 (4%)

 Peri-operative treatment

  Neo-adjuvant chemotherapy

10 (9%)

  Adjuvant chemotherapy

38 (36%)

  Adjuvant radiation therapy

14 (13%)